Literature DB >> 17083013

Extended-spectrum beta-lactamases in multidrug-resistant Escherichia coli: changing the therapy for hospital-acquired and community-acquired infections.

Marion S Helfand, Robert A Bonomo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083013     DOI: 10.1086/508891

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.

Authors:  Dror Marchaim; Teena Chopra; Ashish Bhargava; Christopher Bogan; Sorabh Dhar; Kayoko Hayakawa; Jason M Pogue; Suchitha Bheemreddy; Christopher Blunden; Maryann Shango; Jessie Swan; Paul R Lephart; Federico Perez; Robert A Bonomo; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2012-06-11       Impact factor: 3.254

Review 2.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

3.  Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone.

Authors:  Priyaranjan Pattanaik; Christopher R Bethel; Andrea M Hujer; Kristine M Hujer; Anne M Distler; Magdalena Taracila; Vernon E Anderson; Thomas R Fritsche; Ronald N Jones; Sundar Ram Reddy Pagadala; Focco van den Akker; John D Buynak; Robert A Bonomo
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

4.  First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.

Authors:  James S Lewis; Monica Herrera; Brian Wickes; Jan E Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

5.  Comparison of extended spectrum β-lactamases-producing Escherichia coli with non-ESBLs-producing E.coli: drug-resistance and virulence.

Authors:  Sha Li; Yan Qu; Dan Hu; Yong-Xin Shi
Journal:  World J Emerg Med       Date:  2012

6.  Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.

Authors:  Andrea Endimiani; John M Depasquale; Sandra Forero; Federico Perez; Andrea M Hujer; Daneshia Roberts-Pollack; Paul D Fiorella; Nancy Pickens; Brandon Kitchel; Aida E Casiano-Colón; Fred C Tenover; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2009-09-09       Impact factor: 5.790

Review 7.  The role of carbapenems in initial therapy for serious Gram-negative infections.

Authors:  James J Rahal
Journal:  Crit Care       Date:  2008-05-21       Impact factor: 9.097

8.  Antimicrobial Susceptibility Pattern of Extended-spectrum Beta-lactamases Producing Organisms Isolated in a Tertiary Care Hospital, Bangladesh.

Authors:  Mohammad Jobayer; Zeenat Afroz; Sultana Shazeda Nahar; Ayesha Begum; Shahin Ara Begum; S M Shamsuzzaman
Journal:  Int J Appl Basic Med Res       Date:  2017 Jul-Sep
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.